Biologic variability in plasma glucose, hemoglobin A1c, and advanced glycation end products associated with diabetes complications.
about
Cryoprotectant Toxicity: Facts, Issues, and QuestionsVariables involved in the discordance between HbA1c and fructosamine: the glycation gap revisitedPersistence of individual variations in glycated hemoglobin: analysis of data from the Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Randomized TrialComprehensive identification of glycated peptides and their glycation motifs in plasma and erythrocytes of control and diabetic subjectsAssessment of carotid arterial wall elasticity in type 2 diabetes mellitus patients with microalbuminuria by real-time ultrasound elastography.When the blood glucose and the HbA(1c) don't match: turning uncertainty into opportunity.Oral L-Arginine Administration Improves Anthropometric and Biochemical Indices Associated With Cardiovascular Diseases in Obese Patients: A Randomized, Single Blind Placebo Controlled Clinical Trial.Assessment of carotid atherosclerosis in type 2 diabetes mellitus patients with microalbuminuria by high-frequency ultrasonography.Glycation gap is associated with macroproteinuria but not with other complications in patients with type 2 diabetes.Enzymatic repair of Amadori products.Inflammatory pattern recognition receptors and their ligands: factors contributing to the pathogenesis of preeclampsia.Glycemic control in the clinical management of diabetic patients.Are there better alternatives than haemoglobin A1c to estimate glycaemic control in the chronic kidney disease population?Evaluation of glycated albumin (GA) and GA/HbA1c ratio for diagnosis of diabetes and glycemic control: A comprehensive review.Modulation of red blood cell population dynamics is a fundamental homeostatic response to diseaseRelationship between hemoglobin glycation index and extent of coronary heart disease in individuals with type 2 diabetes mellitus: a cross-sectional study.Fibroblast growth factor: will this hormone be the hemoglobin A1c for managing phosphorus balance in chronic kidney disease?Genome-wide meta-analysis in Japanese populations identifies novel variants at the TMC6-TMC8 and SIX3-SIX2 loci associated with HbA1c.Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial.Physical Activity Throughout Adolescence and Hba1c in Early Adulthood: Birth Cohort Study.Glycated albumin. A glycemic control index to be reevaluated
P2860
Q27021819-79ABFEEF-9AF1-4998-8EFF-673295BBABD3Q28533840-B666F7FB-E57E-4F22-AB49-B627B786A218Q33877199-7BF160FE-00F7-4167-A12C-51D4A30E4629Q35083863-3833AA09-C65B-45E8-BD3E-C9077949D478Q36014557-F9914102-E757-4744-8A60-958A712203ECQ36426844-B2AD139E-0C54-4E71-BA33-7ABD8BA82218Q36569630-AA2B7362-DE8F-4E13-9CF4-2A762EE209D5Q36729116-9E7A5592-D35A-4039-BF84-208604FE868BQ36942120-CDA0EA87-8A85-421F-A31A-74E968823ED0Q37802272-C5B56D3A-20DC-40CB-B2DC-9EE9CAD28BF7Q37850374-68AD7AF3-2648-42BB-A70A-CDE659285688Q38067533-A526A65B-F0BB-4AB9-8E1D-AF92AC7F3C6EQ38182542-E5000415-1190-4D31-B844-7E8EC4A7554BQ39231126-3AA7DC63-F1CF-46B5-AB1C-E0E13C183A5AQ41477950-52032D60-CE5F-4829-95DC-72FAEC056092Q42270747-A4F2BE8E-C98F-44F4-BFD2-D7017A9AB544Q42705008-C8DCFA0B-20AE-41F8-B3D3-DB6A5BE8E489Q47145661-C8DAE800-7DDA-4423-8EC3-7A5F09198A9DQ47199486-DBB5EA89-2D1F-45CB-8B8F-3FA7960B3CF4Q50907003-C952F01B-BD0F-499F-8324-971C56CB7114Q58055764-5FFB361B-8172-4B3F-B124-AA62D2A4DBE9
P2860
Biologic variability in plasma glucose, hemoglobin A1c, and advanced glycation end products associated with diabetes complications.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Biologic variability in plasma ...... d with diabetes complications.
@en
Biologic variability in plasma ...... d with diabetes complications.
@nl
type
label
Biologic variability in plasma ...... d with diabetes complications.
@en
Biologic variability in plasma ...... d with diabetes complications.
@nl
prefLabel
Biologic variability in plasma ...... d with diabetes complications.
@en
Biologic variability in plasma ...... d with diabetes complications.
@nl
P2860
P1476
Biologic variability in plasma ...... d with diabetes complications.
@en
P2093
R David G Leslie
Robert M Cohen
P2860
P304
P356
10.1177/193229680900300403
P577
2009-07-01T00:00:00Z